G
GNPX
Genprex Inc
1.310
-0.060-4.38%After Hours: 1.310 0.000 0.00%16:42 04/08 EDT
OPEN/PREV CLOSE1.390/1.370
TODAY RANGE1.260-1.440
VOL635.49K
MARKET CAP11.85M
52 WEEK RANGE1.260-55.00
AVG VOL (3M)1.01M
% TURNOVER7.03%
TURNOVER--
P/E (TTM)-0.0753
% RANGE13.12%
EPS(TTM)-17.3994
P/E(FORWARD)-0.0097
P/B0.5416
BVPS2.419
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.71M
SHARES OUTSTANDING9.04M
NEXT EARNINGS05/11-05/15
FREE FLOAT8.94M
LOT SIZE1
EX-DATE10/21/2025
News
Press Releases
Financial Reports
Profile
Reuters·03/30 21:42
Genprex FY25 net loss narrows 23% to $16M
Benzinga·03/27 17:10
Top Ranking Stock Picker From Congress Is Back Buying Small Cap Stocks Again: Here Are The Tickers
TipRanks·03/18 12:35
Genprex Highlights New Reqorsa Preclinical Data at AACR
TipRanks·03/18 11:11
Genprex collaborators present on use of Reqorsa at AACR meeting
Reuters·03/10 11:04
Genprex executives to attend BIO Europe Spring 2026
Benzinga·02/25 23:20
Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying
Benzinga·02/23 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
TipRanks·02/23 13:51
Genprex Secures Key Global Patents for REQORSA Therapy
TipRanks·02/23 13:12
Genprex granted Japanese and EU patents for Reqorsa Gene Therapy
TipRanks·02/10 13:53
Genprex Gains Australian Patent Acceptance for REQORSA Therapy
TipRanks·02/10 13:05
Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
Same Industry
Name/Symbol
Change%
Price